by Jordana Choucair | Aug 10, 2022 | Life Sciences
ndo International PLC said it is negotiating with senior lenders over what is likely to result in a filing for chapter 11 bankruptcy. The pharmaceutical manufacturer has reached opioid settlements with several states – including Alabama, Florida, New York, Texas, and...
by Jordana Choucair | Aug 9, 2022 | Life Sciences
The Biden administration will proceed with a plan to have patients receive one-fifth of the recommended monkeypox vaccine. The U.S. Department of Health and Human Services (HHS) must issue a new emergency declaration granting the Food and Drug Administration (FDA) to...
by Jordana Choucair | Aug 5, 2022 | Life Sciences
PhRMA and its 31 board members sent a letter to every member of Congress yesterday imploring them to vote against Democrats’ reconciliation package. PhRMA CEO Steve Ubl said in an interview that lawmakers “who vote for this bill will not get a free...
by Jordana Choucair | Aug 5, 2022 | Life Sciences
Amgen Inc. secured a deal to buy ChemoCentryx Inc. for $3.7 billion, giving the biotech company access to the potential blockbuster drug Tavneos. The drug is used to treat patients with a rare type of blood vessel inflammation that generated $5.4 million in sales in...
by Jordana Choucair | Aug 4, 2022 | Life Sciences
A federal court jury ordered Eli Lilly to pay $61 million to settle charges that it intentionally skimped on payments for the Medicaid drug rebate program. The company’s failure to pay allegedly resulted in losses for the federal government program and Medicaid...
by Jordana Choucair | Aug 3, 2022 | Life Sciences
CivicaScript, the subsidiary of the hospital-owned nonprofit Civica Rx, will release its first drug manufactured and sold by the company. The drug is a generic version of the prostate cancer prescription drug abiraterone and will likely cost patients thousands of...
Recent Comments